How ‘good’ bacteria from fecal transplants reduce peanut allergy
Peer-Reviewed Publication
Updates every hour. Last Updated: 25-Oct-2026 19:17 ET (25-Oct-2026 23:17 GMT/UTC)
Some 33 million Americans have severe food allergies. Now, researchers at Boston Children’s Hospital may have found a promising solution. In a small clinical trial, Rima Rachid, MD, director of the Food Allergy Program and the Allergen Immunotherapy Program, and Talal Chatila, MD, director of translational immunology, and their colleagues found that some participants with peanut allergies experienced a higher tolerance to peanuts months after receiving a fecal transplant from a healthy donor without food allergies. Their findings are published today in Science Translational Medicine.
Researchers at Baylor College of Medicine have developed a drug called CS18 that disrupts the ability of cancer cells to survive therapy. The findings support exploring the possibility of using CS18 to treat human cancer in the future.
With the support of National Institutes of Health funding, Johns Hopkins Medicine investigators, led by pathologist Aaron W. James, M.D., Ph.D., previously discovered that sensory neurons in skeletal tissue are constantly sensing their environment and are quick to respond to injuries. Through new research published in Science Translational Medicine, they describe how this response profoundly affects growth plates, the soft cartilage at the end of bones in children that support normal growth and development, and how it responds to targeted treatment in mice.
Following a growth plate injury, a rapid invasion of nerve fibers and blood vessels triggers the formation of an unwanted “bony bar,” a rigid bone-like structure that can ultimately impede recovery and lead to stunted or altered bone growth. Through this new research, the team found inhibiting TrkA+ sensory neurons with long-acting bupivacaine, an FDA-approved nerve-numbing anesthetic, reduced this abnormal growth by up to 60%.
Spinal cord injuries affect an estimated 15 to 20 million people worldwide, often causing lasting impairments in movement, sensation, and independence. Such injuries can be especially devastating when they occur at the level of the neck, where damaged spinal circuits disrupt signals that control the diaphragm, the main muscle used for breathing. Despite advances in emergency care and rehabilitation, no approved therapies exist to rebuild the neurons and connections lost after a spinal cord injury. But new research from scientists at Gladstone Institutes offers hope for a regenerative treatment in the future.
The Gerontological Society of America (GSA) — the oldest and largest interdisciplinary organization focused on aging — is proud to announce its newest elected officers. These individuals were chosen by GSA’s membership, which consists of more than 6,000 researchers, educators, and practitioners.
WASHINGTON—The ALARA+ (“As Low And As Light As Reasonably Achievable”) Coalition, comprised of nine leading medical societies, today released a suite of resources to help hospital leadership and decisionmakers implement enhanced radiation and occupational safety guidelines for clinicians and staff working in the fluoroscopy laboratory, often called “cath labs” or “angio suites.”
In response to a growing occupational health crisis, the core principle of ALARA+ is to move beyond reducing harm by building safety into the workplace, equipment, and standards of care for all cath lab team members. The new implementation toolkits translate recently published ALARA+ guidelines into practical steps to protect cath lab team members from both occupational radiation exposure and orthopedic injuries related to protective equipment.
Available at www.ALARA-PLUS.org